Clinical Trials Browser

Phase 2 × Carcinoma, Medullary × pembrolizumab × Clear all

NCT03072160 2021-02-11

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

Phase 2 Completed

17 enrolled 14 charts

Carcinoma, Medullary